{"disease":{"id":"chronic-urticaria-idiopathic","name":"chronic urticaria idiopathic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05936567","title":"Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"Incyte Corporation","has_results":true},{"nct_id":"NCT02892682","title":"The Role of the Coagulation Pathways in Recurrent Angioedema","phase":"NA","overall_status":"TERMINATED","enrollment_count":96,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06555328","title":"Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":73,"lead_sponsor_name":"InflaRx GmbH","has_results":false},{"nct_id":"NCT03858634","title":"A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT05916937","title":"Extending Omalizumab Treatment Intervals in Patients With Chronic Spontaneous Urticaria","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Simon Francis Thomsen","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}